These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Kelemen LE; Goodman MT; McGuire V; Rossing MA; Webb PM; ; Köbel M; Anton-Culver H; Beesley J; Berchuck A; Brar S; Carney ME; Chang-Claude J; Chenevix-Trench G; ; Cramer DW; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Fredericksen ZS; Fridley BL; Gates MA; Gayther SA; Gentry-Maharaj A; Høgdall E; Kjaer SK; Lurie G; Menon U; Moorman PG; Moysich K; Ness RB; Palmieri RT; Pearce CL; Pharoah PD; Ramus SJ; Song H; Stram DO; Tworoger SS; Van Den Berg D; Vierkant RA; Wang-Gohrke S; Whittemore AS; Wilkens LR; Wu AH; Schildkraut JM; Sellers TA; Goode EL; Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1822-30. PubMed ID: 20570913 [TBL] [Abstract][Full Text] [Related]
3. A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS. Rosmarin D; Palles C; Pagnamenta A; Kaur K; Pita G; Martin M; Domingo E; Jones A; Howarth K; Freeman-Mills L; Johnstone E; Wang H; Love S; Scudder C; Julier P; Fernández-Rozadilla C; Ruiz-Ponte C; Carracedo A; Castellvi-Bel S; Castells A; Gonzalez-Neira A; Taylor J; Kerr R; Kerr D; Tomlinson I Gut; 2015 Jan; 64(1):111-20. PubMed ID: 24647007 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. Hamzic S; Kummer D; Froehlich TK; Joerger M; Aebi S; Palles C; Thomlinson I; Meulendijks D; Schellens JHM; García-González X; López-Fernández LA; Amstutz U; Largiadèr CR Pharmacol Res; 2020 Feb; 152():104594. PubMed ID: 31838077 [TBL] [Abstract][Full Text] [Related]
6. Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population. Xu WH; Long JR; Zheng W; Ruan ZX; Cai Q; Cheng JR; Zhao GM; Xiang YB; Shu XO Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):579-84. PubMed ID: 19190136 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer. Dong SQ; Wang TM; Zhang JB; He YQ; Xue WQ; Wu ZY; Yang DW; Cao LJ; Huang JW; Li XZ; Zhang PF; Zheng XH; Jia WH Cancer Res Treat; 2021 Jul; 53(3):724-732. PubMed ID: 33285053 [TBL] [Abstract][Full Text] [Related]
8. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Wang J; Wang B; Bi J; Di J Breast Cancer Res Treat; 2011 Jul; 128(1):203-9. PubMed ID: 21188629 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. Williams KA; Terry KL; Tworoger SS; Vitonis AF; Titus LJ; Cramer DW PLoS One; 2014; 9(2):e88334. PubMed ID: 24551091 [TBL] [Abstract][Full Text] [Related]
11. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer. Lin S; Yue J; Guan X; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B Cancer Commun (Lond); 2019 Oct; 39(1):57. PubMed ID: 31601265 [TBL] [Abstract][Full Text] [Related]
13. Gene set-based analysis of mucinous ovarian carcinoma. Chang CM; Wang PH; Horng HC Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population. Feng W; Guo X; Huang H; Xu C; Li Y; Guo S; Zhao Z; Li Q; Lu D; Jin L; Wang J; Jiang G; Wu J Curr Probl Cancer; 2019 Feb; 43(1):66-74. PubMed ID: 30180988 [TBL] [Abstract][Full Text] [Related]
15. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers. Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577 [TBL] [Abstract][Full Text] [Related]
17. Polymorphic thymidylate synthase gene impacts on overall survival of patients with epithelial ovarian cancer after platinum-based chemotherapy. Biason P; Visentin M; Talamini R; Stopar A; Giorda G; Lucia E; Campagnutta E; Toffoli G Pharmacogenomics; 2012 Nov; 13(14):1609-19. PubMed ID: 23148637 [TBL] [Abstract][Full Text] [Related]
18. Hisamatsu T; McGuire M; Wu SY; Rupaimoole R; Pradeep S; Bayraktar E; Noh K; Hu W; Hansen JM; Lyons Y; Gharpure KM; Nagaraja AS; Mangala LS; Mitamura T; Rodriguez-Aguayo C; Eun YG; Rose J; Bartholomeusz G; Ivan C; Lee JS; Matsuo K; Frumovitz M; Wong KK; Lopez-Berestein G; Sood AK Mol Cancer Ther; 2019 Jan; 18(1):162-172. PubMed ID: 30305341 [TBL] [Abstract][Full Text] [Related]
19. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China. Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040 [TBL] [Abstract][Full Text] [Related]